Literature DB >> 18834618

Activated protein C levels in obesity and weight loss influence.

Eva Solá1, Silvia Navarro, Pilar Medina, Amparo Vayá, Amparo Estellés, Antonio Hernández-Mijares, Francisco España.   

Abstract

Obesity is associated with a high risk of cardiovascular events. Several haemostatic disturbances which could contribute to this increased risk have been described in obesity; nevertheless, the state of coagulation inhibitors has been scarcely studied in these patients. The aim of the present study was to compare activated protein C levels in obese patients and in a control group, and to evaluate the effect of weight loss. In 67 severe or morbid obese patients, an evaluation was performed at baseline and 3 months after diet. The same determinations were performed in 67 healthy volunteers with normal body weight. We also quantified the levels of protein C and prothrombin fragment 1+2. Obese patients showed significantly higher levels of activated protein C, protein C and fragment 1+2. No correlation was found between activated protein C and fragment 1+2 levels in obese patients. After three months of diet, a significant decrease in activated protein C and fragment 1+2 was observed. In conclusion, activated protein C levels are increased in obese patients, but only a minor fraction of this increase may be explained by the higher thrombin generation and C protein levels. Activated protein C levels decrease with weight loss, due in part to a thrombin generation reduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834618     DOI: 10.1016/j.thromres.2008.07.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  The association between BMI and plasma cytokine levels in patients with acute lung injury.

Authors:  Renee D Stapleton; Anne E Dixon; Polly E Parsons; Lorraine B Ware; Benjamin T Suratt
Journal:  Chest       Date:  2010-04-30       Impact factor: 9.410

2.  Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.

Authors:  Karen M Kassel; A Phillip Owens; Cheryl E Rockwell; Bradley P Sullivan; Ruipeng Wang; Ossama Tawfik; Guodong Li; Grace L Guo; Nigel Mackman; James P Luyendyk
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

3.  Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Authors:  Karen M Kassel; Bradley P Sullivan; Wei Cui; Bryan L Copple; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-07-26       Impact factor: 4.307

4.  Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity.

Authors:  Takehiko Oka; Yuhei Nishimura; Liqing Zang; Minoru Hirano; Yasuhito Shimada; Zhipeng Wang; Noriko Umemoto; Junya Kuroyanagi; Norihiro Nishimura; Toshio Tanaka
Journal:  BMC Physiol       Date:  2010-10-21

5.  Changes in Dietary Fat Content Rapidly Alters the Mouse Plasma Coagulation Profile without Affecting Relative Transcript Levels of Coagulation Factors.

Authors:  Audrey C A Cleuren; Vicky T Blankevoort; Janna A van Diepen; Daniël Verhoef; Peter J Voshol; Pieter H Reitsma; Bart J M van Vlijmen
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 6.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

Review 7.  Obesity-associated oxidative stress: strategies finalized to improve redox state.

Authors:  Isabella Savini; Maria Valeria Catani; Daniela Evangelista; Valeria Gasperi; Luciana Avigliano
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.